Share on LinkedInShare on LinkedIn

ARTICLE · 14 MAY 2020

Government Lifts Restrictions On Export Of 24 API Pharma Ingredients With Immediate Effect

S&A Law Offices
S&A Law Offices
Contributor
S&A Law Offices

S&A Law Offices

S&A Law Offices is a full-service law firm headquartered in Delhi NCR. The firm has 300+...

View firm profile
Explore more from S&A Law Offices

The government, with immediate effect, has lifted the restrictions on export of 24 API pharma ingredients.

IndiaCoronavirus (COVID-19)

The government, with immediate effect, has lifted the restrictions on export of 24 API pharma ingredients including Tinidazole, Metronidazole, Acyclovir, Vitamin B1, B6 and B12, Progesterone, Chloramphenicol, Ornidazole, formulations made of Vitamin B1.1

Background

On March 06, the Union Minister of State for Shipping, and Chemical and Fertilizers, had said that the government has imposed short term restrictions on some active pharmaceutical ingredients (API) with regards to coronavirus preparedness. The ease on curbs on export 24 APIs assumed significance as some pharma companies had raised concerns over these restrictions. The total number of COVID-19 positive cases in India has reached 10k+ according to the latest government estimates. However, export restriction on paracetamol, a common fever and pain reliever, and its formulations would remain, as per the resource information.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from